Asensus Surgical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.3011
- Today's High:
- $0.3161
- Open Price:
- $0.31
- 52W Low:
- $0.28
- 52W High:
- $1.18
- Prev. Close:
- $0.32
- Volume:
- 1331304
Company Statistics
- Market Cap.:
- $129.10 million
- Book Value:
- 0.333
- Revenue TTM:
- $7.00 million
- Operating Margin TTM:
- -1121.9%
- Gross Profit TTM:
- $-3785000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -37.3%
- Return on Equity TTM:
- -68.23%
Company Profile
Asensus Surgical Inc had its IPO on 1992-11-12 under the ticker symbol ASXC.
The company operates in the Healthcare sector and Medical Devices industry. Asensus Surgical Inc has a staff strength of 183 employees.
Stock update
Shares of Asensus Surgical Inc opened at $0.31 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.3 - $0.32, and closed at $0.3.
This is a -5.78% slip from the previous day's closing price.
A total volume of 1,331,304 shares were traded at the close of the day’s session.
In the last one week, shares of Asensus Surgical Inc have increased by +0.5%.
Asensus Surgical Inc's Key Ratios
Asensus Surgical Inc has a market cap of $129.10 million, indicating a price to book ratio of 0.8323 and a price to sales ratio of 12.4108.
In the last 12-months Asensus Surgical Inc’s revenue was $7.00 million with a gross profit of $-3785000 and an EBITDA of $-70037000. The EBITDA ratio measures Asensus Surgical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Asensus Surgical Inc’s operating margin was -1121.9% while its return on assets stood at -37.3% with a return of equity of -68.23%.
In Q1, Asensus Surgical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 8.4%.
Asensus Surgical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.34 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Asensus Surgical Inc’s profitability.
Asensus Surgical Inc stock is trading at a EV to sales ratio of 1.8265 and a EV to EBITDA ratio of -0.2193. Its price to sales ratio in the trailing 12-months stood at 12.4108.
Asensus Surgical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $96.52 million
- Total Liabilities
- $10.88 million
- Operating Cash Flow
- $29.74 million
- Capital Expenditure
- $64000
- Dividend Payout Ratio
- 0%
Asensus Surgical Inc ended 2024 with $96.52 million in total assets and $0 in total liabilities. Its intangible assets were valued at $96.52 million while shareholder equity stood at $79.72 million.
Asensus Surgical Inc ended 2024 with $0 in deferred long-term liabilities, $10.88 million in other current liabilities, 239000.00 in common stock, $-883153000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $18.74 million and cash and short-term investments were $56.43 million. The company’s total short-term debt was $775,000 while long-term debt stood at $0.
Asensus Surgical Inc’s total current assets stands at $71.56 million while long-term investments were $958000.00 and short-term investments were $37.70 million. Its net receivables were $1.21 million compared to accounts payable of $4.97 million and inventory worth $8.84 million.
In 2024, Asensus Surgical Inc's operating cash flow was $29.74 million while its capital expenditure stood at $64000.
Comparatively, Asensus Surgical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.3
- 52-Week High
- $1.18
- 52-Week Low
- $0.28
- Analyst Target Price
- $1.65
Asensus Surgical Inc stock is currently trading at $0.3 per share. It touched a 52-week high of $1.18 and a 52-week low of $1.18. Analysts tracking the stock have a 12-month average target price of $1.65.
Its 50-day moving average was $0.39 and 200-day moving average was $0.54 The short ratio stood at 15.46 indicating a short percent outstanding of 0%.
Around 115.4% of the company’s stock are held by insiders while 1083.6% are held by institutions.
Frequently Asked Questions About Asensus Surgical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company’s products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.